Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Enaksha Wickremsinhe

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
Bioanalysis|May 2, 2015
Dried blood spot analysis for rat and dog studies: validation, hematocrit, toxicokinetics and incurred sample reanalysisEnaksha Wickremsinhe
Analytical Chemistry|December 25, 2013
Fully-automated approach for online dried blood spot extraction and bioanalysis by two-dimensional-liquid chromatography coupled with high-resolution quadrupole time-of-flight mass spectrometryRegina V Oliveira, Jack Henion, Enaksha Wickremsinhe
The AAPS Journal|September 12, 2024
ICH M10 Bioanalytical Method Validation Guideline-1 year LaterFaye Vazvaei-Smith, Enaksha Wickremsinhe, Eric Woolf, et al.
Bioanalysis|April 12, 2019
Microsampling for quantitative bioanalysis, an industry update: output from an AAPS/EBF surveyShefali R Patel, Peter Bryan, Neil Spooner, et al.
Pharmaceutics|December 5, 2013
Preclinical absorption, distribution, metabolism, and excretion of an oral amide prodrug of gemcitabine designed to deliver prolonged systemic exposureEnaksha Wickremsinhe, Jingqi Bao, Richard Smith, et al.
Biopharmaceutics & Drug Disposition|October 10, 2014
Evaluation of the likelihood of a selective CHK1 inhibitor (LY2603618) to inhibit CYP2D6 with desipramine as a probe substrate in cancer patientsScott M Hynes, Enaksha Wickremsinhe, Wei Zhang, et al.
The AAPS Journal|August 19, 2025
Case Studies on the Use of Patient-centric Sampling for Clinical Studies in Pharmaceutical Drug DevelopmentShefali Patel, Mike Baratta, Peter Bryan, et al.
Journal of Pharmacy & Pharmaceutical Sciences : a Publication of the Canadian Society for Pharmaceutical Sciences, Societe Canadienne Des Sciences Pharmaceutiques|January 7, 2017
Evaluation and Optimization of Blood Micro-Sampling Methods: Serial Sampling in a Cross-Over Design from an Individual MouseNita J Patel, Enaksha Wickremsinhe, Yu-Hua Hui, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 12, 2018
A First-in-Human Phase 1 Study of LY3023414, an Oral PI3K/mTOR Dual Inhibitor, in Patients with Advanced CancerJohanna C Bendell, Anna M Varghese, David M Hyman, et al.
Bioanalysis|June 20, 2020
Recommendations for singlet-based approach in ligand binding assays: an IQ Consortium perspectiveRenuka Pillutla, Boris Gorovits, Carol Gleason, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Bioanalysis|May 2, 2015
Dried blood spot analysis for rat and dog studies: validation, hematocrit, toxicokinetics and incurred sample reanalysisEnaksha Wickremsinhe
Analytical Chemistry|December 25, 2013
Fully-automated approach for online dried blood spot extraction and bioanalysis by two-dimensional-liquid chromatography coupled with high-resolution quadrupole time-of-flight mass spectrometryRegina V Oliveira, Jack Henion, Enaksha Wickremsinhe
The AAPS Journal|September 12, 2024
ICH M10 Bioanalytical Method Validation Guideline-1 year LaterFaye Vazvaei-Smith, Enaksha Wickremsinhe, Eric Woolf, et al.
Bioanalysis|April 12, 2019
Microsampling for quantitative bioanalysis, an industry update: output from an AAPS/EBF surveyShefali R Patel, Peter Bryan, Neil Spooner, et al.
Pharmaceutics|December 5, 2013
Preclinical absorption, distribution, metabolism, and excretion of an oral amide prodrug of gemcitabine designed to deliver prolonged systemic exposureEnaksha Wickremsinhe, Jingqi Bao, Richard Smith, et al.
Biopharmaceutics & Drug Disposition|October 10, 2014
Evaluation of the likelihood of a selective CHK1 inhibitor (LY2603618) to inhibit CYP2D6 with desipramine as a probe substrate in cancer patientsScott M Hynes, Enaksha Wickremsinhe, Wei Zhang, et al.
The AAPS Journal|August 19, 2025
Case Studies on the Use of Patient-centric Sampling for Clinical Studies in Pharmaceutical Drug DevelopmentShefali Patel, Mike Baratta, Peter Bryan, et al.
Journal of Pharmacy & Pharmaceutical Sciences : a Publication of the Canadian Society for Pharmaceutical Sciences, Societe Canadienne Des Sciences Pharmaceutiques|January 7, 2017
Evaluation and Optimization of Blood Micro-Sampling Methods: Serial Sampling in a Cross-Over Design from an Individual MouseNita J Patel, Enaksha Wickremsinhe, Yu-Hua Hui, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 12, 2018
A First-in-Human Phase 1 Study of LY3023414, an Oral PI3K/mTOR Dual Inhibitor, in Patients with Advanced CancerJohanna C Bendell, Anna M Varghese, David M Hyman, et al.
Bioanalysis|June 20, 2020
Recommendations for singlet-based approach in ligand binding assays: an IQ Consortium perspectiveRenuka Pillutla, Boris Gorovits, Carol Gleason, et al.
Pageof 2